newsfilter
← Latest News
Business Wire·

Alto Neuroscience Announces Participation in Upcoming Investor Conferences

Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the